Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

41.14
+1.363.42%
Post-market: 41.150.0100+0.02%16:31 EDT
Volume:2.86M
Turnover:116.84M
Market Cap:7.81B
PE:-11.64
High:41.36
Open:39.95
Low:39.63
Close:39.78
Loading ...
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 25, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jul 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]